BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mavromanoli AC, Barco S, Konstantinides SV. Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition. Res Pract Thromb Haemost 2021;5. [PMID: 34027284 DOI: 10.1002/rth2.12509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 De Caterina R, Prisco D, Eikelboom JW. Factor XI inhibitors: cardiovascular perspectives. Eur Heart J 2023;44:280-92. [PMID: 36263776 DOI: 10.1093/eurheartj/ehac464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bitsadze VO, Slukhanchuk EV, Khizroeva JK, Tretyakova MV, Tsibizova VI, Gashimova NR, Nakaidze IA, Elalamy I, Gris J, Makatsariya AD. Anticoagulants: dose control methods and inhibitors. Akušerstvo, ginekologiâ i reprodukciâ 2022;16:158-175. [DOI: 10.17749/2313-7347/ob.gyn.rep.2022.293] [Reference Citation Analysis]
3 Forgo G, Micieli E, Ageno W, Castellucci LA, Cesarman-Maus G, Ddungu H, De Paula EV, Dumantepe M, Guillermo Esposito MC, Konstantinides SV, Kucher N, McLintock C, Ní Áinle F, Spyropoulos AC, Urano T, Hunt BJ, Barco S. An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta-analysis. J Thromb Haemost 2021. [PMID: 34822215 DOI: 10.1111/jth.15607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]